Conservative Management of Morbidly Adherent Anterior Situated Placenta

M

Mansoura University Hospital

Status

Completed

Conditions

Placenta Accreta

Treatments

Procedure: Cervico- isthmic compression suture
Procedure: Anterior wall uterine resection:

Study type

Interventional

Funder types

Other

Identifiers

NCT04579172
MS.20.09.1246

Details and patient eligibility

About

Placenta accreta is defined as abnormal trophoblast invasion of part or the entire placenta into the myometrium of the uterine wall. Placenta accreta spectrum (PAS), formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, percreta, and accreta. An important risk factor of placenta accreta is placenta previa in the presence of a uterine scar. Placenta previa is an independent risk factor for placenta accreta.Additional reported risk factors for placenta accreta include increased maternal age and multiparity, other prior uterine surgery, prior uterine curettage,uterine irradiation, Asherman syndrome, uterine leiomyomata, uterine anomalies, hypertensive disorders of pregnancy and smoking. (1,2) Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion also and rates of maternal death are increased for women with PAS. Additionally, patients with PAS are more likely to require hysterectomy at the time of delivery or during the postpartum period and have longer hospital stays states.(3) According to FIGO Classification of PAS Disorders 2019 There are three grades. Grade 1: abnormally adherent placenta (placenta adherent or accreta) - attached directly to the surface of the middle layer of the uterine wall (myometrium) without invading it, Grade 2: abnormally invasive placenta (increta) - invasion into the myometrium and Grade 3: abnormally invasive placenta (percreta) invasion may reach surrounding pelvic tissues, vessels and organs.(4) Nowadays, fertility sparing and conservative methods can be applied. These methods include placenta left in situ, cervical inversion technique , triple-P procedure, cervico-isthmic compression suture and anterior wall uterine resection

Full description

Study Design & Area: Randomized controlled trial (RCT) of pregnant women recruited from Department of Obstetrics and Gynecology Mansoura University Hospitals during September 2020 until September 2021 and may be extended if needed. The study groups will undergo: Informed consent History: Personal: (age, duration of marriage, special habits). Menstrual history Obstetric: (parity, mode of delivery, fetal outcome). Present history of any medical or obstetric problems. Past medical and surgical history. Clinical examination : General and obstetric examination Calculation of Gestational Age : Gestational age will be calculated by adding 280 days (40weeks) to the first day of the last menstrual period or by ultrasound. Investigation: Lab investigation:- Complete blood count , Bleeding profile, international normalization ratio, liver function tests, kidney function tests Ultrasound: Ultrasound Finding:- i. Establish the presence of a living fetus. ii. Estimate the age of the pregnancy. iii. Diagnose congenital abnormalities of the fetus. iv. Evaluate the position of the fetus. v. Determine the amount of amniotic fluid around the baby. vi. Assess fetal growth. vii. Assess fetal well-being. viii. Evaluate the position of the placenta. - When the antepartum diagnosis of placenta accreta is made, it is usually based on ultrasound findings in the second or third trimester. Sonographic findings that may be suggestive of placenta accreta include: Loss of normal hypoechoic retroplacental zone. Multiple vascular lacunae (irregular vascular spaces) within placenta, giving "Swiss cheese" appearance. Blood vessels or placental tissue bridging uterine-placental margin, myometrial-bladder interface. Retroplacental myometrial thickness of <1 mm. 3 - Color Doppler criteria: Diffuse or focal lacunar flow pattern. Sonolucent vascular lakes with turbulent flow typified by high-velocity (peak systolic velocity>15 cm/s) and low-resistance waveform. Markedly dilated vessels over the peripheral subplacental region (6) Surgical Procedure: Preparation of the patient before surgery: Patient will shave their pubic hair , take a shower with an antiseptic soap, antibiotic prophylaxis and urinary catheter insertion . Caesarean section steps : After spinal anesthesia and skin sterilization Abdominal Incision: Pfannenstiel incision then cut the subcutaneous fat and rectus sheath and blunt entry into the peritoneal cavity .

Enrollment

40 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1- Patient with FIGO classification of PAS disorders Grade 1 & Grade 2 which diagnosed by :

  • Loss of normal hypoechoic retroplacental zone.
  • Multiple vascular lacunae (irregular vascular spaces) within placenta, giving "Swiss cheese" appearance.
  • Retroplacental myometrial thickness of less 1 mm. 2- Patient welling to preserve fertility.

Exclusion criteria

1- Patient with FIGO classification of PAS disorders Grade 3 (interruption of the hyperechoic border between the uterine serosa and bladder by US).

2- Age : >40 years old. 3- Patient has medical disorders: cardiac disease, uncontrolled DM, chronic renal disease, chronic liver disease.

4- Patient who refuse to participate in the study.

Trial design

40 participants in 2 patient groups

Group A
Experimental group
Description:
Circular isthmic-cervical sutures
Treatment:
Procedure: Cervico- isthmic compression suture
Group B
Experimental group
Description:
Resection of the infiltrated part of anterior uterine wall
Treatment:
Procedure: Anterior wall uterine resection:

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems